Search Results 2131-2140 of 20190 for Receptor

  1. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  2. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer - Mayo Clinic

    Hormonal therapy (e.g., androgen receptor [AR] antagonists, 5 alpha reductase inhibitors, estrogens) Note: Treatment with bicalutamide and nilutamide within ...

  3. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a ...

  4. Neurology - Doctors - Mayo Clinic

    ligodendrocyte glycoprotein antibody-associated disease, NMDA receptor antibody encephalitis, Autoimmune epilepsy, Autoimmune encephalitis, Chorea. Show more ...

  5. Publications - Frank X. Downey, III, M.D. - Mayo Clinic

    The association between glucagon-like peptide 1 receptor agonists therapy and outcomes after heart transplant. J Heart Lung Transplant. 2026 Jan 9 Epub 2026 ...

  6. Brain Tumor Program - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  7. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    ... receptor (CAR)-T within 60 days * Active hepatitis B or hepatitis C * Known active cytomegalovirus (CMV) infection * Uncontrolled immune thrombocytopenic ...

  8. Publications - Jorge A. Trejo-Lopez, M.D. - Mayo Clinic

    ... receptor-independent neuronal spread. J Virol. 2025 Jan 31; 99 (1):e0175024 Epub 2024 Dec 06. View PubMed; Vizcaino MA, Giannini C, Vaubel RA, Nguyen AT ...

  9. EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway - Mayo Clinic

    ... Receptor pathway. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  10. A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

    ... receptor, dupilumab, anti-IgE antibodies, omalizumab) or systemic corticosteroids with a daily dose >10 mg of prednisone or equivalent, during 5 half-lives ...